MonicaMirela(Museteanu)MitaMD
Oncology • Los Angeles, CABreast Cancer, Sarcoma
Professor of Medicine, University of California Los Angeles David Geffen SOM, Professor of Medicine, Cedars-Sinai Medical Center, Oncology, SOCCI
Dr. Mita is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
8700, beverly bvd
Cedars Sinai Madical Center
Los Angeles, CA 90048Phone+1 310-248-6729Fax+1 310-248-6740- Is this information wrong?
Summary
- Dr. Monica Mita is an oncologist in Los Angeles, CA and is affiliated with multiple hospitals in the area, including UCLA Medical Center-Santa Monica and Cedars-Sinai Medical Center. She received her medical degree from Carol Davila University of Medicine and Pharmacy and has been in practice 25 years. She also speaks multiple languages, including French. She specializes in breast cancer and is experienced Sarcoma, neoplasm staging, and general medical oncology and experimental therapeutics- Phase 1. She is currently the Co-Director of Experimental Therapeutics at Cedars Sinai Cancer.
Education & Training
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 2002 - 2005
Carol Davila University of Medicine and PharmacyClass of 1992
Certifications & Licensure
CA State Medical License 2011 - 2025
TX State Medical License 2006 - 2025
AL State Medical License 2005 - 2024
Clinical Trials
- Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Head and Neck Carcinoma Start of enrollment: 2008 Aug 01
- Safety of MP470 in Combination With Standard-of-Care Chemotherapy Regimens to Treat Solid Tumors Start of enrollment: 2007 Nov 01
- S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors Start of enrollment: 2008 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsSingle-cell and spatial profiling identify three response trajectories to pembrolizumab and radiation therapy in triple negative breast cancer.Shiao, S., Gouin, K., Ing, N., Ho, A., Basho, R., Shah, A., Mebane, R., Zitser, D., Martinez, A., Mevises, N., Ben-Cheikh, B., Henson, R., Mita, M., McAndrew, P., Karl...> ;Cancer Cell. 2024 Jan 8
- 1 citationsPhase 1 study to determine the safety and dosing of autologous PBMCs modified to present HPV16 antigens (SQZ-PBMC-HPV) in HLA-A*02+ patients with HPV16+ solid tumors.Antonio Jimeno, Joaquina Baranda, Wade T Iams, Jong Chul Park, Monica Mita, Michael S Gordon, Matthew Taylor, Neesha Dhani, Alexis D Leal, Prakash Neupane, Cathy Eng, ...> ;Investigational New Drugs. 2023 Apr 1
- 4 citationsAKT/mTOR signaling modulates resistance to endocrine therapy and CDK4/6 inhibition in metastatic breast cancers.Maysa M Abu-Khalaf, K Alex Hodge, Christos Hatzis, Elisa Baldelli, Emna El Gazzah, Frances Valdes, William M Sikov, Monica M Mita, Neelima Denduluri, Rita Murphy, Dani...> ;NPJ Precision Oncology. 2023 Feb 16
- Join now to see all
Lectures
- Pharmacodynamic and clinical activity of RGX-104, a first-in-class immunotherapy targeting the liver-X nuclear hormone receptor (LXR), in patients with refractory mali...2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
- New Therapeutics in Oncology: The Road to Personalized MedicineCedars Sinai Medical Center, Los Angeles, California - 10/26/2012
Press Mentions
One Man’s Search for the DNA Data That Could Save His LifeNovember 19th, 2020
Forever Young? There’s Officially an Anti-Aging Pill for DogsOctober 8th, 2016
The Pill That Could Make Your Dog Live LongerOctober 6th, 2016
Professional Memberships
- Member
Other Languages
- French
Hospital Affiliations
Cedars-Sinai Medical CenterLos Angeles, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
